Remedy Pharmaceuticals, Inc. — Form D/A
Remedy Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2012-03-06. The offering totals $793K, of which $793K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-03-06
- Form: D/A
- Accession: 0001541381-12-000020
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $793K
- Amount sold: $793K
- Investors: 3
- Date of first sale: 2011-10-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-167542
Issuer
- Name: Remedy Pharmaceuticals, Inc.
- CIK: 0001501657
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 122 WEST 27TH STREET, NEW YORK, NY, 10001
- Phone: 212-586-2226
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| DAVID M GELIEBTER | Director | NEW YORK, NY |
| SVEN JACOBSON | Director | NEW YORK, NY |
| SVEN JACOBSON | Executive Officer | NEW YORK, NY |
| DAVID GELIEBTER | Director | NEW YORK, NY |
| DAVID M. GELIEBTER | Director | NEW YORK, NY |
Other filings by this issuer (7)
More